8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
Meet the Veristat team at ASCO, May 31st to June 4th in Chicago
Oncology development expertise that turns complex data into confident regulatory direction
If you are transitioning your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or are looking to recruit patients quickly to get your early phase trials running, or just need medical writing, biostatistical,or pharmacovigilance support for your programs – Veristat can help.
For 30 years, Veristat has helped pharmaceutical and biotech companies accelerate their clinical trials and commercialize their therapies by delivering Science-First solutions across the development lifecycle.
Oncology/Hematology Experience in the Past 5 Years
We provide impactful solutions on a full-service or functional service basis, integrating strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies.
Our expertise encompasses traditional cancer treatments, devices/diagnostics, and specialized therapies, including vaccines, gene and cell therapies, and immunotherapies.
Don't miss this opportunity to connect with us at the Conference and learn more about how Veristat is advancing the development of new oncology therapies.
The Science-First CRO.™
Veristat team members, AJ Mills, Vice President, Global Commercial, and Gabriela Rosu, Senior Director, Global Medical Affairs, will be at the venue, ready to listen to your needs and share Veristat’s expertise. Discover what makes Veristat a distinguished name in the clinical research industry.
Arrange a meeting by completing the form on the right side of this page.
Website: ASCO 2024
Meet with us at ASCO 2024 by filling out the form below.
8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...